A B S T R A C T
Time-to-event analyses are frequently used in nephrology research, for instance, when recording time to death or time to peritonitis in dialysis patients. Many papers have pointed out the important issue of competing events (or competing risks) in such analyses. For example, when studying one particular cause of death it can be noted that patients also die from other causes. Such competing events preclude the event of interest from occurring and thereby complicate the statistical analysis. The Kaplan-Meier approach to calculating the cumulative probability of the event of interest yields invalid results in the presence of competing risks, thus the alternative cumulative incidence competing risk (CICR) approach has become the standard. However, when kidney transplant is the competing event that prevents observing the outcome of interest, CICR may not always be the matter of interest. We discuss situations where both the Kaplan-Meier and the CICR approach are not suitable for the purpose and point out alternative analysis methods for such situations. We also look at the suitability and interpretation of different estimators for relative risks. In the presence of transplant as a competing risk, one should very clearly state the research question and use an analysis method that targets this question.
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I N T R O D U C T I O N
Competing events that preclude the occurrence of an event of interest are commonly encountered in nephrology research. For instance, when a particular cause of death while on dialysis is of interest, it can be noted that patients also die from other causes. The statistical analysis of competing risks data has received much attention in recent nephrology literature [1] [2] [3] . These papers point out the limitations of the Kaplan-Meier (KM) estimator when assessing the cumulative probability of the event of interest over time. The KM method assumes non-informative censoring, meaning that patients who are censored are at the same risk as patients who remain in the study. This assumption is violated by competing risks data. In general, this leads to an overestimation of risks. The common advice is to account for competing risks by using another type of analysis, often referred to as the cumulative incidence competing risk (CICR) method [1] [2] [3] . This method calculates the cumulative proportion of patients experiencing the event of interest while accounting for the fact that part of the patients will never get to experience the event, as they will experience a competing event.
However, the results of such a CICR analysis may not always be of interest. In case the competing event is not an inevitable thing, such as 'death from other causes', but is a medical intervention such as transplantation, the interest may lie in a different matter. In particular, we may want to know what would happen if the patient chooses not to undergo transplantation.
Suppose we study a group of patients who are on a waiting list to receive transplantation. We follow these patients for some years and are interested in the mortality risk. In particular, we are interested in the a priori risk of dying without a transplant. We are not considering deaths occurring after undergoing transplantation, hence we are not evaluating the risk or benefit of the transplantation itself. During the follow-up period, some patients will receive a kidney transplant, after which we cannot observe the event of interest, i.e. death while on dialysis, anymore. Transplant is thus a competing risk. We can have different research questions related to these data.
(i) We may want to know the risk of dying before transplantation. This information will be useful in counselling These two research questions target an entirely different matter and in this article we show that they require a different analysis approach. In the Estimating absolute risks section, we go over a detailed example and show how both research questions can be handled. The focus of this section is on estimating absolute risks. In the Estimating relative risks section, we look at the assessment of the effect of risk factors and interventions, i.e. relative risks. In the Application to the NECOSAD study section, we illustrate the impact of the analysis methods using data from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) study [4] . Finally, we close with a discussion and give suggestions on how to analyse and interpret competing risks data in dialysis patients.
E S T I M A T I N G A B S O L U T E R I S K S
Let us consider a hypothetical study in dialysis patients (example partly adapted from Noordzij et al. [2] , Sapir-Pichhadze et al. [3] and Lau et al. [5] ). Twenty dialysis patients who are on the waiting list for a transplant are followed for 6 years. During these years, seven patients died while on dialysis and six patients received a kidney transplant. The timing of these events is depicted in Table 1 . We will now look at the two research questions posed in the Introduction section and show how they can and cannot be answered with this example data set.
Using the KM method to assess the risk of dying before transplantation A very common approach to calculating cumulative event probabilities is the KM method [6] . It can deal with situations where we could not observe the exact time of the event, in our case death on dialysis, in all patients. For some patients, we only know that the event has not yet occurred at a certain time point and the data of such patients are called 'censored'. Censoring can occur in different ways, for instance, because patients are still alive and on dialysis at the end of the study period or because patients have moved to another location for reasons unrelated to their health status. In dialysis patients, the occurrence of transplantation makes it impossible to observe death on dialysis anymore. Naively, we could therefore treat a transplantation event in the same way as the above-mentioned censoring situations. Table 1 shows how the KM approach would then estimate the cumulative risk of death. First, the probability that a patient is still alive by year t is estimated by multiplying the probabilities of not dying in any of the years before. These peryear survival probabilities are estimated as the ratio of patients surviving that year divided by the patients at risk of dying in that year, i.e. not having died, not having had a transplant and not being censored for other reasons before that year. The cumulative risk of death by year t can be derived in two ways. Either by directly calculating one minus the probability of being still alive by year t or, to enhance the comparison with the other methods, by first multiplying all per-year probabilities of death on dialysis (j ¼ 0, . . . , t) by the probability of still being alive by year j À 1 and summing these. In the example data set, the KM method estimates that the 6-year risk of dying on the waiting list is 46%.
However, censoring due to a competing risk is very different from other types of censoring. When data are censored for a reason like 'end of follow-up period of the study', we can reasonably assume that the mortality risk of a patient who was censored was at that moment comparable to that of patients who were followed for a longer period. This assumption is called non-informative censoring and it is the key assumption underlying the KM method. Patients who received a transplant, however, are not likely to have comparable risk to patients who did not, so this assumption is violated. As a result, the KM estimates will be biased. In particular, for this first research question (the risk of dying while on dialysis) the KM method will always give too high risk estimates, as the risk of dying on dialysis after being transplanted is, by definition, zero and not comparable with patients who are on the waiting list longer, as the KM method assumes. The KM method will always give an overestimation of the risk of dying while on the waiting list and, therefore, cannot be used to answer this research question.
Using the CICR method to assess the risk of dying before transplantation
An alternative approach to dealing with competing risks is the CICR method [7] . The calculation of this method is also shown in Table 1 . It more or less follows the same lines as the KM method, with one big distinction: the probability of experiencing the event of interest is calculated conditional not only on not having experienced the event of interest before, but also on not having had the competing event before. The probability of death on dialysis in each year is therefore calculated by multiplying the relative proportion of deaths in that year by the probability of not having died and not having had a transplant ii54 N. van Geloven et al.
before that year. The method does not assume non-informative censoring for the competing events like the KM method, but instead the method assumes that once you have the competing event, you cannot experience the event of interest thereafter. This assumption perfectly matches the first research question, the risk of dying while on the waiting list, as one will not die on dialysis after transplantation. Therefore, the CICR is suitable to answer this question. Based on these data, our best estimate for the 6-year risk of dying on the waiting list is 35%. Note that when there are no other censoring mechanisms (i.e. with the exception of patients who experience the competing event, all patients are followed for the complete follow-up period), the CICR method of estimating the cumulative risk is equal to the plain ratio of deaths divided by the total number of patients starting the study. In the example, this is the case and the ratio 7/20 ¼ 0.35 gives the same result as the CICR method. This amplifies the fact that patients who have a competing risk are basically counted as 'non-events' in the CICR method. When we do have other 'true' censoring mechanisms, and hence censoring for reasons other than the competing event, then the CICR estimation method assumes those mechanisms to be non-informative. Thus the cumulative risk can no longer be calculated by a plain ratio. We then need the procedure as outlined in Table 1 to derive the correct risk estimates and correct standard errors.
Using the KM method to assess the risk of dying if never transplanted
How would the KM assumption of non-informative censoring match the situation when we want to answer the second research question, i.e. estimate the risk of dying in a scenario where transplantation does not exist? Here we need to make an assumption about what would have happened to patients who got a transplant-had they not been transplanted. The KM method assumes that their prognosis would have been the same as for patients who were on dialysis for a longer period. How realistic is this? That is hard to say. There may be different reasons why patients require transplantation. Maybe a patient undergoes transplantation because he or she would otherwise die soon. The risk of death on dialysis for such a patient was likely to be higher than the risk of death for the other patients who remained on dialysis. On the other hand, a patient may have gotten a transplant because he or she was expected to have many healthy years ahead, assuring a long 'second life' for the donor kidney. In that situation, the risk of dying on dialysis in the transplanted patient was probably lower than the risk of 
Cumulative probability of not having the event by year t is calculated as the conditional probability of not having the event in year t times the cumulative probability of not having the event up to year t À 1. This is referred to as the KM survival estimator.
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Risk of having the event in year t is calculated as the conditional risk of the event in year t times the cumulative probability of not having the event up to year t À 1. Cumulative risk of death is the sum of the risk of death in this year and in the previous years. Note that for the KM method, another way of getting this result is by calculating 1 À cumulative probability of not dying. In this way the calculation can better be compared to the CICR method. d Cumulative probability of not dying and not receiving a transplant by year t is calculated as the conditional probability of dying or receiving a transplant in year t times the cumulative probability of not dying and not having had a transplant up to year t À 1.
e Risk of dying in year t is calculated as the conditional risk of dying in year t times the cumulative probability of not dying and not having received a transplant up to year t À 1.
T r a n s p l a n t a s a c o m p e t i n g r i s k [8] . Subject-matter knowledge should thus be used to think about how much the KM method could be off. If additional patient characteristics that influence the probability of getting a transplant are recorded, it is advised to perform additional analyses (see Advanced analyses section below ). We conclude that the KM method can only be used to answer this research question under the strict and untestable assumption of non-informative censoring.
Using the CICR method to assess the risk of dying if never transplanted
Can the CICR method answer the second research question, i.e. can it estimate the risk of dying in a no-transplantation scenario? The CICR method assumes that patients who got a transplant had at that moment zero probability of dying while on dialysis. This assumption is inappropriate for this research question, as under a no-transplantation scenario these patients would clearly be at risk of death. The CICR method will always underestimate the risk and cannot be used to answer this research question.
Upper and lower bounds for the risk of dying if never transplanted
Estimating the probability of the event in a scenario where the competing risk would not exist is very difficult. We just saw that both the KM method and the CICR are not equipped for it. Actually, this quantity is not directly available from the data without making strong and untestable assumptions about the degree of relationship between the competing events. Therefore, a wise thing to do is to look at the two extreme scenarios of maximal positive and maximal negative dependence. The true risk of death if not transplanted must be contained somewhere within these two bounds [9] .
One can show that the lower bound coincides with the CICR estimate if the censoring for reasons other than a transplant is uninformative [10] . In this way, we see that the CICR estimate of 35% for 6-year on-dialysis mortality derived earlier is a lower bound estimate.
To derive a higher bound, we reason in the opposite direction. What if all those patients who got a transplant would have died on the day of transplantation had they stayed on dialysis? In such a worst-case scenario, we would assume that all six transplanted patients would have died if not transplanted, leading to an upper bound of (6 þ 7)/20 ¼ 65% for 6-year on-dialysis mortality.
We can thus say that based on the example data, we estimate the 6-year risk of dying to be between 35 and 65%, if not transplanted. Note that the upper and lower bounds should not be interpreted as a confidence interval (CI). When the sample size increases, the bounds will not become narrower as would be the case with a CI.
More advanced analyses to assess the risk of dying if never transplanted
Sometimes we can obtain a more precise estimate of the risk of dying if not transplanted. More advanced analysis techniques exist that aim to get the best view on the amount of dependence between the competing events by making additional assumptions. Here we give a short description of three such analysis techniques. Further details can be found in the references.
Inverse probability of censoring weighting (IPCW).
With IPCW, we first make a model that relates measured covariates to the competing transplantation event. From this model, for each patient and at each time point we obtain an estimated probability of not yet being transplanted by that time. These probabilities are used as (inverse) weights in the analysis of on-dialysis mortality. In this way a pseudo-population is created, which would have been observed had the competing risk of transplantation not existed [11] . The IPCW method depends on several assumptions [12] [13] [14] [15] . Most importantly, IPCW assumes that patients with the same covariate values have the same death-on-dialysis prognosis, irrespective of whether they get a transplant or not. This assumption entails that you have no unmeasured confounding, you have sufficient data to estimate the effects of these confounders at each time point and you correctly specify the models (appropriate functional forms for the predictors in the weighted model for on-dialysis mortality as well as in the censoring model used for construction of the weights) [11, 13] . Also, there must have been some degree of randomness in the decision to transplant. For example, if all women receive transplantation while all men do not, we cannot perform these corrections. In other words, we need to know exactly which patient characteristics led to the decision to transplant and according to which algorithm. Although usually not all these assumptions hold, the IPCW assumptions are often much more FIGURE 1: Cumulative risk curves for the NECOSAD data. If we want to answer the first research question, the risk of dying before transplantation, we should look at the CICR bound. If we want to answer the second research question, the risk of dying if never transplanted, all estimates between the upper and lower bounds are consistent with the data. The KM curve is valid if the risk of transplantation is independent of the risk of dying. The curves remain at zero during the first 3 months since patients are considered to be stable on dialysis from that moment on and thus patients with shorter follow-up times were excluded. Multiple imputation. Multiple imputation (MI) is a known method for dealing with missing data [16] . In the current competing risks setting, times to death on dialysis for patients who got a transplant are considered to be missing data and a new (larger) time interval is imputed, reflecting the time to death that would have been observed if there had not been a transplantation. The MI approach has the same rationale as the IPCW one: it tries to reconstruct the transplantation decisions from measured covariates. It then relates the covariates to the death on dialysis event.
Patients then get two risk scores: one for death on dialysis and one for transplantation. The censored death-on-dialysis time for patients who got a transplant is imputed based on patients who had similar values for both risk scores but who were not yet transplanted. This is done multiple times and results are pooled to correct for the uncertainty of imputing [17] . It is also possible to use external information on the amount by which the time to death should be increased [18] .
Copulas. Copulas provide a way to model the dependence between two competing time-to-event variables by directly specifying the dependence structure. Such a method can be useful if external knowledge exists either on the degree and structure of the correlation between the event distributions [18] or on the parametric shape of the two event distributions [19, 20] .
E S T I M A T I N G R E L A T I V E R I S K S
We now focus our attention on assessment of the effect of risk factors and interventions, i.e. on relative risks. Again, in the presence of competing risks we have to look carefully at what research question we are posing to find the correct analysis method. Two popular analysis methods for estimating the effect of covariates in competing risks data are the cause-specific (CS) approach and the subdistribution (SD) approach. A common way of estimating CS hazard ratios is using a Cox proportional hazards model for the event of interest, where competing events are considered to be censored observations. We will therefore refer to the CS approach as the 'Cox method'. A common way of estimating SD hazard ratios is using the Fine and Gray model, and we will refer to the SD approach as the 'Fine and Gray method'. Many papers on competing risks conclude that when the research targets aetiological questions the Cox method should be used, whereas when targeting prediction the Fine and Gray method should be used [1, 2, 3, 5] . We look at the details of this general advice in light of the situation under study where death on dialysis is the event of interest and where transplantation is the competing event.
Suppose we are studying the relative risk of death on dialysis of men with respect to women. The research can then focus on two different research questions related to the two questions posed in the Introduction section:
(i) We may want to know whether men are more likely to die before receiving a transplantation than women.
(ii) Alternatively, we may want to know whether men are more likely to die than women if nobody receives transplantation.
Using the Cox method to assess the relative risk of dying before transplantation
The idea behind the Cox approach is that the hazard (instantaneous risk) of the event of interest is compared within the subset of patients who have not yet experienced the event of interest and who have not yet experienced the competing event at a particular time point. This is illustrated in Table 1 in the 'CS hazard' row. For relative CS hazards, we can think of looking at the waiting list every day and noting how many of the men who are on the list that day die the same day and compare that to how many of the women on the list that day die on the same day. The Cox model averages that comparison over all days assuming that the ratio is constant over time. The CS hazard ratio can be a useful measure to quantify the relative risk of dying while on the waiting list. We must realize, however, that it expresses a comparison between current waitlisted transplant candidates. It cannot be interpreted as a relative measure for cumulative risk. Hence, if a man and a woman are both placed on the waiting list, the CS hazard ratio cannot predict who has a higher risk of dying in the future while on the waiting list. This is because the question 'who has a higher risk of dying in the future while still on the waiting list' is also influenced by who gets a transplant sooner (the risk of the competing event). That component is not actively taken into account in the calculation of CS hazard ratios. In case men have a higher risk of dying on dialysis than women, but if at the same time men received transplantation sooner, it may be that there are relatively fewer men dying on dialysis than women. The CS hazard ratio for ondialysis mortality will still be >1 for men versus women. We, therefore, conclude that the Cox approach is suited to answer the first research question, but it should not be interpreted as a comparison of cumulative risks. For this reason, a Cox model may well be suited if the focus is on understanding biological, or aetiological, questions [21] . But a single Cox model for the event of interest cannot be used when the focus of the research is on prediction of cumulative risk. In order to make such predictions, the estimated CS hazard ratio should be combined with the relative risk of transplantation.
Using the Fine and Gray method to assess the relative risk of dying before transplantation
The idea behind the Fine and Gray method is that the hazard of the event of interest is compared based on the subset of patients who have not yet experienced the event of interest at a particular time point. Patients who experience the competing event remain in the calculations of later time points as having 'no event'. This is illustrated in Table 1 in the 'SD hazard' row. The Fine and Gray method assumes proportional SD hazards over time [22] . In our example, we can think of looking each day at the men who die the same day relative to those who are still on the waiting list plus those who got a transplant before and compare this ratio to the same ratio among women. The SD hazard ratio in the Fine and Gray model combines both the association between gender and the risk of dying and the association T r a n s p l a n t a s a between gender and the risk of receiving a transplant. In case men have a higher risk of dying on dialysis than women, but if at the same time men receive transplantation much sooner, it may be that there are relatively fewer men dying on dialysis than women. The SD hazard ratio for on-dialysis mortality could then drop to <1 for men versus women. The SD hazard ratio can, with this 'joint effect' in mind, be used to estimate the relative risk of dying while on the waiting list. Since the SD hazard focuses on a joint effect, it is advised to use the SD hazard method only in cases where the focus is on prediction [19] .
Using the Cox method to assess the relative risk of dying if never transplanted What if we wanted to know who should be given priority on the transplant waiting list based on an estimate of the probability of death if never transplanted? Then we need the relative hazard of men versus women under the hypothetical scenario that nobody would be transplanted. As noted previously, such an interpretation cannot be made without making strong assumptions on the degree of the relationship between the competing events. In the Cox setting, we would have to assume that in the data set at hand, conditional on the other covariates in the model, the probability of getting a transplant is independent of the probability of death. This means that among patients with similar characteristics, the probability of getting a transplant is independent of the risk of dying. Only then could the CS hazard ratio be used to answer this research question. The assumption of conditional independence between the competing events cannot be tested based on the data and should be supported by external subject-matter knowledge. We conclude that the CS hazard ratio can only be used for estimation of the relative risk of dying if not transplanted if all risk factors for transplantation are known and are correctly adjusted for in the analysis.
Using the Fine and Gray method to assess the relative risk of dying if never transplanted As noted above, the SD hazard ratio is directly influenced by possible differences in transplantation rates between men and women. Therefore, it cannot be used to assess the difference in risk of death in the absence of transplantation. If the patient factor or intervention of interest has no relation with the chance of getting a transplant, then the SD hazard ratio will be similar to the CS hazard ratio [23] .
A P P L I C A T I O N T O T H E N E C O S A D S T U D Y
We applied the KM, CICR (lower bound) and upper bound methods to data from the NECOSAD study, an observational renal replacement study following patients after initial dialysis [22] . This data set was analysed previously with a multistate model, also taking into account deaths after transplantation [24] . For our analysis, we selected 1689 patients who started on either haemodialysis or peritoneal dialysis and we focused only on death while on dialysis. During the median follow-up period of 2.4 years, 953 patients died while on dialysis, 642 got a transplant and 284 were still alive and without transplant until the last moment of follow-up. Figure 1 shows the estimated curves up to 8 years since the start of dialysis. For answering the first research question, i.e. the risk of dying before getting a transplant, it is clear that we should use the CICR curve. We can read from the CICR curve that new patients who start on dialysis have a risk of 58% of dying while on dialysis within 8 years if they have not yet been transplanted by that time. If they are transplanted earlier, they would of course still be at risk for death, but this is not taken into account in the 58% estimate.
For the second research question, i.e. the risk of dying if never transplanted, it is less clear what curve we should use. If we assume that in our data the probability of getting a transplant is unrelated to the mortality risk, then we would read off the KM curve and learn that in the hypothetical scenario nobody would be transplanted during the first 8 years and we would expect 90% of the patients to die. However, the data that we collected, which have a mixture of patients who did and who did not receive a transplant, are consistent with an estimate ranging from as low as 58% to as high as 98%. We thus have a lot of uncertainty about our estimate.
To obtain a more precise estimate, one should use more advanced analysis methods such as IPCW, MI or copulas, where additional information from the data, preferably time-dependent covariates, are used to learn what the most plausible degree of dependence between transplantation and mortality is. Table 2 summarizes the applicability of the discussed analysis methods to the two research questions posed in the Introduction. In contrast to many papers that suggest the CICR method is always the best analysis method when facing competing risks, we argue that in case the competing risk is a medical intervention such as a transplantation, CICR is not always the method to consider. The CICR method and SD hazard models like the Fine and Gray model should only be used if the focus is on the risk of events before patients receive a transplantation. These estimates are valid given the current transplantation practice and current waiting list times. For example, such methods can be used to study time to peritonitis on dialysis, given that once transplantation is received, there is a zero chance of this event.
C O N C L U S I O N A N D D I S C U S S I O N
However, in case a competing risk is caused by a medical intervention such as transplantation, the research question may also focus on a different dimension. Namely, what would be the risk of on-dialysis events if a patient never receives a transplant? Such questions are of interest if we want to know which subgroups should be given priority on a transplant waiting list. These are difficult questions to answer, as we only have data from the situation where, contrary to the situation we are interested in, transplants did occur in our data. We show that the KM method and the CS hazards model (Cox model) are only valid under the strict assumption of (conditional) independent censoring, i.e. if the probability of getting a transplant is unrelated to the event of interest (conditional on covariates). As this assumption may not hold in many situations and cannot be tested on the data, additional analyses are needed to study such questions. It is wise to look at upper and lower bound estimates. 
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